2023 / 04

Next Paper
DOI: 10.47183/mes.2023.059

ORIGINAL RESEARCH

The specifics of encephalitis after COVID-19

Bobrov MP1, Voitenkov VB1,2, Ekusheva EV1,3, Kiparisova ES1
About authors

1 Postgraduate Education Academy of the Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies, Federal Medical Biological Agency, Moscow, Russia

2 Pediatric Research and Clinical Center of Infectious Diseases, Federal Medical Biological Agency, St. Petersburg, Russia

3 Belgorod State National Research University, Belgorod, Russia

Correspondence should be addressed: Maxim Pavlovich Bobrov
Volokolamskoye sh., 91, Moscow, 125371, Russia; ur.xobni@4202_vorbob_skam

About paper

Author contribution: Bobrov MP — literature analysis, data collection, manuscript authoring; Voitenkov VB — literature analysis, study planning, data interpretation, manuscript authoring; Ekusheva EV — study planning, collection and analysis of literature; Kiparisova ES — collection and analysis of literature.

Compliance with ethical standards: the submitted article has not been previously published, all borrowings are correct.

Received: 2023-11-03 Accepted: 2023-12-20 Published online: 2023-12-29
|
  1. Ellul M, Solomon T. Acute encephalitis — diagnosis and management. Clin Med (Lond). 2018; 18 (2): 155–9. DOI: 10.7861/clinmedicine.18-2-155. PMID: 29626021. PMCID: PMC6303463.
  2. Kumar R. Understanding and managing acute encephalitis. F1000Res. 2020; 9: F1000 Faculty Rev-60. DOI: 10.12688/f1000research.20634.1. PMID: 32047620. PMCID: PMC6993835.
  3. Lobzin YuV, Pilipenko VV, Gromyko YuN. Meningity i entsefality. SPb.: Foliant, 2006; 128 p. Russian.
  4. Kulakov DA, Predko VA. Struktura neyroinfektsiy sredi patsientov reanimatsionnogo profilya. Forcipe. 2019; 2 (S1): 473–4. EDN BMWLZN. Russian.
  5. Skripchenko NV, Ivanova GP, Trofimova TN, Murina EA, Skripchenko EYu, Surovtseva AV. Encephalitis in children: Clinical, etiological, and topical characteristics. Russian Bulletin of Perinatology and Pediatrics. 2014; 59 (3): 104–11. Russian.
  6. Costa BKD, Sato DK. Viral encephalitis: a practical review on diagnostic approach and treatment. J Pediatr (Rio J). 2020; 96 (1): 12–9. DOI: 10.1016/j.jped.2019.07.006. PMID: 31513761. PMCID: PMC9431993.
  7. Nikolskaya MV, Ratenko TA, Golovina NA. Entsefality v strukture zabolevaniy nervnoy sistemy u gospital'nykh patsientov. Vestnik Penzenskogo gosudarstvennogo universiteta. 2021; 2: 64–8. Russian.
  8. Fominykh VV. Analiz vospalitel'nykh i neyrodegenerativnykh protsessov u patsientov s autoimmunnymi zabolevaniyami tsentral'noy nervnoy sistemy [dissertation]. М., 2019. Russian.
  9. Azizova UM, Bembeeva RTs, Kozyreva AA, Zavadenko NN. AntiNMDA receptor encephalitis. L.O. Badalyan Neurological Journal. 2021; 2 (3): 137–45. DOI: 10.46563/2686-8997-2021-2-3-137-145. EDN JEZLFK. Russian.
  10. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12 (2): 157–65. DOI: 10.1016/s1474-4422(12)70310-1.
  11. Sharipova VH, Bakhadirkhanov MM, Kasimova RI. Therapeutic and diagnostic methods and complications of acute viral encephalitis. The Bulletin of Emergency Medicine. 2020; 13 (4): 39–44. EDN ZPHHQM. Russian.
  12. Poponin NM, Bondarenko AL. Tick-borne encephalitis in the Kirov Region: epidemiology, clinical picture and outcomes. Practical Medicine. 2019; 17 (7): 143–8. EDN IAFWNB. Russian.
  13. Di Vito A, Donato A, Bria J, Donato F, Donato G. Encephalitis lethargica. What is still wrong? Int J Immunopathol Pharmacol. 2023; 37: 3946320231154997. DOI: 10.1177/03946320231154997. PMID: 36716496. PMCID: PMC9892526.
  14. Ulukhanova LU, Karnayeva NS, Yaraliev MM, Gadzhimirzaevа AG, Agaevа SG. Clinical case of encephalitis with antibodies to NMDA receptors. Children infections. 2019; 18 (4): 67–9. DOI: 10.22627/2072-8107-2019-18-4-67-69. EDN VXZXWI. Russian.
  15. Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB. RECOVER Mechanistic Pathway Task Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023; 12: e86002. DOI: 10.7554/eLife.86002.
  16. Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, et al. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021; 71(11): 2192–209. DOI: 10.1007/s12031-020-01767-6. PMID: 33464535. PMCID: PMC7814864.
  17. Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. 2022; 13 (1): 17–23. DOI: 10.1111/cen3.12676. PMID: 34899999. PMCID: PMC8652810.
  18. Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological Sequelae of COVID-19. J Integr Neurosci. 2022; 21 (3): 77. DOI: 10.31083/j.jin2103077.
  19. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris). 2021; 177 (1–2): 51–64. DOI: 10.1016/j.neurol.2020.10.001. PMID: 33446327. PMCID: PMC7832485.
  20. Asiful IM, Cavestro C, Alam SS, Kundu S, Kamal MA, Reza F. Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis. Cells. 2022; 11 (16): 2575. DOI: 10.3390/cells11162575.
  21. Kahwagi J, Diagne R, Fall M, Basse A, Ndiaye M, Diop AG. Post infectious encephalitis at Covid19: About one pediatric observation and review of the literature. Rev Neurol (Paris). 2021; 177 (1–2): 132–4. DOI: 10.1016/j.neurol.2020.09.001. PMID: 32951859. PMCID: PMC7494321.
  22. Varadan B, Shankar A, Rajakumar A, et al. Acute hemorrhagic leukoencephalitis in a COVID-19 patient — a case report with literature review. Neuroradiology. 2021; 63: 653–61. DOI: 10.1007/s00234-021-02667-1.
  23. Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021; 8 (6): e1080. DOI: 10.1212/NXI.0000000000001080. PMID: 34452974. PMCID: PMC8404207.
  24. Matthews E, Beckham JD, Piquet AL, et al. HerpesvirusAssociated Encephalitis: an Update. Curr Trop Med Rep. 2022; 9: 92–100. DOI: 10.1007/s40475-022-00255-8.
  25. Dotsenko ML, Dotsenko EA. Aktivatsiya gerpes-virusnoy infektsii kak proyavlenie postkovidnogo sindroma. Retsept. 2023; 26 (3): 350–65. DOI: 10.34883/PI.2023.26.3.005. EDN WASKZO. Russian.
  26. Gupta S, Dutta A, Chakraborty U, Kumar R, Das D, Ray BK. Post-COVID-19 HSV encephalitis: a review. QJM. 2022; 115 (4): 222–7. DOI: 10.1093/qjmed/hcac060. PMID: 35199176. PMCID: PMC9383498.
  27. Nabizadeh F, Balabandian M, Sodeifian F, Rezaei N, Rostami MR, Naser Moghadasi A. Autoimmune encephalitis associated with COVID-19: A systematic review. Mult Scler Relat Disord. 2022; 62: 103795. DOI: 10.1016/j.msard.2022.103795. PMID: 35472834. PMCID: PMC8983076.
  28. Ndondo AP, Eley B, Wilmshurst JM, Kakooza-Mwesige A, Giannoccaro MP, Willison HJ, et al. Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective. Front Immunol. 2022; 13: 833548. DOI: 10.3389/fimmu.2022.833548. PMID: 35356001. PMCID: PMC8959857.
  29. Abdelhady M, Husain MA, Hawas Y, Elazb MA, Mansour LS, Mohamed M. Encephalitis following COVID-19 Vaccination: A Systematic Review. Vaccines (Basel). 2023; 11 (3): 576. DOI: 10.3390/vaccines11030576. PMID: 36992160. PMCID: PMC10054808.
  30. Mansour K, Chadli Z, Ghachem I, Fredj NB, Romdhane HB, Fadhel NB, et al. Seronegative acute encephalitis following COVID-19 vaccines: a case series of an overlooked diagnosis with literature review. Eur J Clin Pharmacol. 2023; 79 (7): 975–87. DOI: 10.1007/s00228-023-03510-7. PMID: 37231308. PMCID: PMC10212735.
  31. Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. ClinicalTrials.gov. 2023; Available from: https://clinicaltrials.gov/study/NCT05156723.
  32. Merișescu MM, Luminos ML, Pavelescu C, Jugulete G. Clinical Features and Outcomes of the Association of Co-Infections in Children with Laboratory-Confirmed Influenza during the 20222023 Season: A Romanian Perspective. Viruses. 2023; 15 (10): 2035. DOI: 10.3390/v15102035.
  33. Olsen SJ. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020; 69: 1305–9. DOI: 10.15585/mmwr.mm6937a6.
  34. Merced-Morales A, Daly P, Abd Elal AI, Ajayi N, Annan E, Budd A, et al. Influenza Activity and Composition of the 2022–23 Influenza Vaccine — United States, 2021–22 Season. MMWR Morb Mortal Wkly Rep. 2022; 71 (29): 913–9. DOI: 10.15585/mmwr.mm7129a1.
  35. Schüz ML, Dallmeyer L, Fragkou PC, Omony J, Krumbein H, Hünerbein BL, et al. Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis. Int J Infect Dis. 2023; 137: 16–24. DOI: 10.1016/j.ijid.2023.10.001.
  36. Boeva EV, Belyakov NA, Simakina OE, et al. Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 2. Interference engaged between SARS-CoV-2 and acute respiratory viral infections. Russian Journal of Infection and Immunity. 2022; 12 (6): 1029–39. DOI: 10.15789/2220-7619EAC-1960. Russian.
  37. Vremennye metodicheskie rekomendatsii: profilaktika, diagnostika i lechenie novoy koronavirusnoy infektsii (COVID 19), versiya 18. Moskva. 26.10.2023. Russian.
  38. Nguyen L, Wang C. Anti-NMDA Receptor Autoimmune Encephalitis: Diagnosis and Management Strategies. Int J Gen Med. 2023; 16: 7–2. DOI: 10.2147/IJGM.S397429.
  39. Wei ZD, Liang K, Shetty AK. Complications of COVID-19 on the Central Nervous System: Mechanisms and Potential Treatment for Easing Long COVID. Aging Dis. 2023; 14 (5): 1492–510. DOI: 10.14336/AD.2023.0312. PMID: 37163427. PMCID: PMC10529748.
  40. Zvereva EA, Ivanova AG. Kleshhevoj jencefalit. Prichiny, simptomy, Diagnostika. Sredstva profilaktiki i lechenie. Naukosfera. 2021; (1): 28–32. EDN BPCFGB. Russian.